Position in NVO
as of Jun 30, 2026
· filed Jul 20, 2026
Position Value
$1,450,328
+$559,508 QoQ
Shares Held
30,253
+24.8% QoQ
Ownership
0.001%
of shares outstanding
% of Portfolio
0.06%
of 13F equity value
Holder Rank
#130
of 543 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in NVO Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026IFP Advisors, Inc holds $69,954,680 across 17 Drug Manufacturers - General names. NVO ranks #8 (2.1% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LLY |
ELI LILLY & Co
|
20,352 | $24,410,801 | |
| 2 | ABBV |
AbbVie Inc.
|
52,930 | $13,319,305 | |
| 3 | JNJ |
Johnson & Johnson
|
38,760 | $9,843,877 | |
| 4 | PFE |
Pfizer Inc
|
228,411 | $5,500,136 | |
| 5 | MRK |
Merck & Co., Inc.
|
30,895 | $3,970,007 | |
| 6 | BMY |
Bristol Myers Squibb Co
|
57,120 | $3,291,254 | |
| 7 | AMGN |
Amgen Inc
|
8,216 | $2,975,177 | |
| 8 | NVO |
Novo Nordisk A S
This page
|
30,253 | $1,450,328 |
All Filings in NVO
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $1,450,328 | 30,253 | Shares | Sole | 2026-07-20 | |
| 2026-03-31 | $890,820 | 24,240 | Shares | Sole | 2026-04-13 | |
| 2025-12-31 | $1,369,536 | 26,917 | Shares | Sole | 2026-02-06 | |
| 2025-09-30 | $760,712 | 13,709 | Shares | Sole | 2026-02-06 | |
| 2025-06-30 | $781,375 | 11,321 | Shares | Sole | 2025-07-24 | |
| 2025-03-31 | $591,351 | 8,516 | Shares | Sole | 2025-05-05 | |
| 2024-12-31 | $994,219 | 11,558 | Shares | Sole | 2025-02-04 | |
| 2024-09-30 | $1,305,483 | 10,964 | Shares | Sole | 2025-02-04 | |
| 2024-06-30 | $1,708,026 | 11,966 | Shares | Sole | 2024-07-30 | |
| 2024-03-31 | $1,384,408 | 10,782 | Shares | Sole | 2024-07-30 | |
| 2023-12-31 | $637,872 | 6,166 | Shares | Sole | 2024-01-09 | |
| 2023-09-30 | $385,949 | 4,244 | Shares | Sole | 2023-10-12 | |
| 2023-06-30 | $424,965 | 2,626 | Shares | Sole | 2023-08-14 | |
| 2023-03-31 | $421,561 | 2,649 | Shares | Sole | 2023-04-18 | |
| 2022-12-31 | $553,405 | 4,089 | Shares | Sole | 2023-02-07 | |
| 2022-09-30 | $469,058 | 4,708 | Shares | Sole | 2022-11-08 | |
| 2022-06-30 | $460,763 | 4,135 | Shares | Sole | 2022-09-06 | |
| 2022-03-31 | $459,191 | 4,135 | Shares | Sole | 2022-09-06 | |
| 2021-12-31 | $84,784 | 757 | Shares | Sole | 2022-01-12 | |
| 2021-09-30 | $124,524 | 1,297 | Shares | Sole | 2021-10-06 | |
| 2021-06-30 | $74,052 | 884 | Shares | Sole | 2021-07-13 | |
| 2021-03-31 | $62,430 | 926 | Shares | Sole | 2021-04-30 | |
| 2020-12-31 | $79,000 | 1,131 | Shares | Sole | 2021-01-25 | |
| 2020-09-30 | $114,281 | 1,646 | Shares | Sole | 2020-10-29 | |
| 2020-06-30 | $49,371 | 754 | Shares | Sole | 2020-08-05 | |
| 2020-03-31 | $70,012 | 1,163 | Shares | Sole | 2020-05-12 | |
| No filing history on record for this holder in this stock. | ||||||